Related references
Note: Only part of the references are listed.Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature
Patricia Lopez et al.
JOURNAL OF TRANSPLANTATION (2014)
PULMONARY ALVEOLAR PROTEINOSIS SECONDARY TO SIROLIMUS IN A RENAL TRANSPLANT PATIENT
Kapil Dhawan et al.
CHEST (2013)
A Rare Occurrence of Pulmonary Alveolar Proteinosis after Lung Transplantation
Jeffrey Albores et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
Sean Kirby et al.
DIAGNOSTIC PATHOLOGY (2012)
Paracrine inhibition of GM-CSF signaling by human cytomegalovirus in monocytes differentiating to dendritic cells
Jerome Carlier et al.
BLOOD (2011)
A Rare Case of Sirolimus-Induced Pulmonary Alveolar Proteinosis Treated With Whole Lung Lavage in a Hyperbaric Chamber
Javier Barreda Garcia et al.
CHEST (2011)
Pulmonary alveolar proteinosis in a kidney transplant: a rare complication of sirolimus
Huseyin Kadikoy et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Unusual thoracic problems in patients with malignancies - Case 2. Malignant mesothelioma in a patient with long-standing pulmonary alveolar proteinosis
R Cheewakriangkrai et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Pulmonary alveolar proteinosis
BC Trapnell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis
JF Seymour et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Serological diagnosis of idiopathic pulmonary alveolar proteinosis
T Kitamura et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
